Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis

International Journal for Parasitology Drugs and Drug Resistance(2020)10.1016/j.ijpddr.2020.08.005Source: DataRank Database

Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis is a research paper published in International Journal for Parasitology Drugs and Drug Resistance (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.38)OA: goldTopics (50)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Bärbel Ruttkowski,Patricia Greber,Grant R. Whitman ORCID,Matthew A. Hulverson ORCID,Ryan Choi ORCID

Live enrichment

PubMed:32861205 OpenAlex:https://openalex.org/W3080181755

National Institutes of Health

Grant: 5R01AI089441-05

Calcium Dependent Protein Kinase 1 as a drug target for T. gondii and C. parvum

National Institutes of Health

Grant: 5R21AI140881-02

Development of Dual Efficacy Therapeutic Against Cryptosporidiosis and Giardiasis

National Institutes of Health

Grant: 5R01HD080670-05

Dual Use Therapeutics for Cryptosporidiosis, Toxoplasmosis, and Neosporosis

National Institutes of Health

Grant: 5R21AI123690-02

Coformulation of bumped kinase inhibitors with Artemisinin combination therapy will stop widespread transmission of artemisinin-resistant malaria strains

National Institutes of Health

Grant: 5R01AI111341-04

Bumped Kinase Inhibitors: Novel Therapeutics for Cryptosporidiosis&Toxoplasmosis

NIAID NIH HHS

Grant: R21 AI123690

NIAID NIH HHS

Grant: R21 AI140881

NIAID NIH HHS

Grant: R01 AI089441

NIAID NIH HHS

Grant: R01 AI111341

NICHD NIH HHS

Grant: R01 HD080670

FWCI

0.38

Citation Percentile

0.6%

Citation Trend

2020

2021

2025

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.ijpddr.2020.08.005

publisherhttps://doi.org/10.1016/j.ijpddr.2020.08.005

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32861205

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7442133

repositoryhttps://doaj.org/article/47c64fc23a0a49e6a8eeda0305a2aee7

Fields of Study

Coccidia and coccidiosis researchParasitic Infections and DiagnosticsHelminth infection and control0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsCoccidiosisPiperidinesPyrimidinesQuinolinesSarcocystidaeSwineSwine Diseases

MeSH Terms

AnimalsCoccidiosisPiperidinesPyrimidinesQuinolinesSwineSwine DiseasesSarcocystidae

Keywords

ExcretionCoccidiosisIn vivoIn vitroDiarrheaPharmacologyKinaseBiologyVirologyMedicineInternal medicineVeterinary medicineBiochemistryBiotechnologySwine DiseasesSwineInfectious and parasitic diseasesRC109-216ArticleIsospora suisCDPK1PyrimidinesPiperidinesGrowth inhibitionSarcocystidaeQuinolinesOocyst excretionAnimals

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being